NCT07127952
Correlations of the Microvascular Abnormalities on NVC (Nail Fold Video Capillaroscopy) and GAVE (Gastric Antral Vascular Ectasia) as Seen on EGD
Enrolling by Invitation
NAAges 18–95InterventionalSupportive careMayo ClinicInvestigator-initiated
~75 participants
Updated 2026-01-29 on ClinicalTrials.gov
What's tested:Video Capillaroscopy
At a glance
Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Prevalence and Phenotypic with G.A.V.E
Measured over From enrollment to end of study once the accrual has been met within baseline of Day 1
Conditions
Where it's being run
3 sites across 2 statesWisconsin2
Florida1
Study leadership
- Florentina Berianu, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients 18 years and older with gave diagnosis as pair EGD performed in Gastroenterology as standard of care.
Exclusion
Age less than 18 years of age, pregnant individuals, dialysis dependent, type 2 diabetes, recent hand trauma or manicure (\<2 weeks), routine use of vibratory tools, history of acrocyanosis or erythromelalgia, previous diagnosis of a bleeding disorder, diagnosis of psoriasis, diagnosis of anti-phospholipid syndrome, exposure to toluene or benzoyl, diagnosis of psoriasis, diagnosis of COPD.
What this trial measures
- Prevalence and Phenotypic with G.A.V.EFrom enrollment to end of study once the accrual has been met within baseline of Day 1
Defined the prevalence and phenotype of nail fold video capillaroscopy abnormalities in patients with G.A.V.E.